Benzinga | Apr 30, 2021 08:08AM EDT

Sientra And Butterfly Network Announce Partnership To Provide 'easy access for plastic surgeons to provide real-time, in-office diagnostic screening of their patients.'; Terms Not Disclosed

Sientra, Inc. (NASDAQ:SIEN), a company that offers leading transformative treatments and technologies focused on progressing the art of plastic surgery, today announced a strategic partnership with Butterfly Network, Inc. (NYSE:BFLY), a leader in point-of-care ultrasound ("POCUS"). This partnership strengthens Sientra's strong safety profile, backed by the industry's leading Platinum20(tm) warranty program, by empowering plastic surgeons to evaluate breast implant patients longitudinally using the Butterfly iQ+ and its innovative Ultrasound-on-Chip(tm) technology.



Breast implant surgery is one of the most frequently performed cosmetic or reconstructive surgical procedures in the United States. In recent years, ultrasound has emerged as a powerful tool for monitoring the long-term health of patients with breast implants. Through this unique partnership, Butterfly Network and Sientra are providing easy access for plastic surgeons to provide real-time, in-office diagnostic screening of their patients.

"At Sientra, patient safety and product quality remain our highest priorities, which is why we entrust our breast implants to only the most qualified surgeons in the industry," said Ron Menezes, President and Chief Executive Officer of Sientra. "We are excited to partner with Butterfly Network to build on the long-term clinical and real-world data supporting the safety of our breast implants and equip surgeons with innovative technology to provide superior care to their patients."

"Our partnership with Sientra highlights the ability for Butterfly iQ+ to deliver actionable and diagnostic insights as an advanced assessment tool, allowing for more informed clinical decision making, improving the patient experience," said Dr. Todd Fruchterman, Butterfly Network's President and Chief Executive Officer. "Sientra's commitment to patient safety mirrors our own and complements our innovative approach to transforming care through technology. Butterfly Network's mission is to democratize healthcare by making medical imaging accessible to everyone worldwide. With Sientra, we look forward to raising the bar in implant safety and reimagining the quality of care that patients receive."

As part of Sientra's commitment to safety and innovation, Butterfly iQ+ will be integrated into Sientra's medical education platform and peer-to-peer network.

To purchase the Butterfly iQ+ ultrasound system, visit: www.sientra.com/butterfly. Butterfly iQ+ is a prescription device intended for trained and qualified healthcare professionals only.